PMMR/MSS ADENOCARCINOMA OF THE COLON OR RECTUM
Clinical trials for PMMR/MSS ADENOCARCINOMA OF THE COLON OR RECTUM explained in plain language.
Never miss a new study
Get alerted when new PMMR/MSS ADENOCARCINOMA OF THE COLON OR RECTUM trials appear
Sign up with your email to follow new studies for PMMR/MSS ADENOCARCINOMA OF THE COLON OR RECTUM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New triple therapy aims to shrink tough colorectal tumors before surgery
Disease control Recruiting nowThis study tests whether adding a PD-1 immunotherapy drug to standard chemotherapy and bevacizumab can improve outcomes for people with a specific type of advanced colorectal cancer (pMMR/MSS) before surgery. About 166 participants will be randomly assigned to receive either the …
Matched conditions: PMMR/MSS ADENOCARCINOMA OF THE COLON OR RECTUM
Phase: PHASE3 • Sponsor: Jun Huang • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New hope for tough cancers: experimental drug targets advanced solid tumors
Disease control Recruiting nowThis study tests an experimental drug called GV20-0251 in adults with advanced solid tumors (like lung, head and neck, or colon cancer) that have stopped responding to standard therapies. The goal is to see if the drug can shrink tumors or slow their growth. About 350 participant…
Matched conditions: PMMR/MSS ADENOCARCINOMA OF THE COLON OR RECTUM
Phase: PHASE1, PHASE2 • Sponsor: GV20 Therapeutics • Aim: Disease control
Last updated May 07, 2026 18:42 UTC